SofWave Medical Statistics

Total Valuation

SofWave Medical has a market cap or net worth of ILS 568.04 million. The enterprise value is 493.63 million.

Market Cap	568.04M
Enterprise Value	493.63M

Important Dates

The next estimated earnings date is Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

SofWave Medical has 34.43 million shares outstanding. The number of shares has increased by 0.29% in one year.

Current Share Class	n/a
Shares Outstanding	34.43M
Shares Change (YoY)	+0.29%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	36.65%
Owned by Institutions (%)	16.54%
Float	12.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.68
PB Ratio	6.28
P/TBV Ratio	6.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-31.48
EV / Sales	2.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-56.13

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.05.

Current Ratio	2.43
Quick Ratio	2.05
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.52
Interest Coverage	-16.21

Financial Efficiency

Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -8.57%.

Return on Equity (ROE)	-16.68%
Return on Assets (ROA)	-5.67%
Return on Capital (ROIC)	-8.57%
Revenue Per Employee	1.80M
Profits Per Employee	-134,013
Employee Count	117
Asset Turnover	1.41
Inventory Turnover	2.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.68% in the last 52 weeks. The beta is 0.60, so SofWave Medical's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+22.68%
50-Day Moving Average	1,785.64
200-Day Moving Average	1,781.43
Relative Strength Index (RSI)	39.39
Average Volume (20 Days)	20,229

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SofWave Medical had revenue of ILS 210.53 million and -15.68 million in losses. Loss per share was -0.46.

Revenue	210.53M
Gross Profit	158.69M
Operating Income	-13.56M
Pretax Income	-14.70M
Net Income	-15.68M
EBITDA	-9.83M
EBIT	-13.56M
Loss Per Share	-0.46

Full Income Statement

Balance Sheet

The company has 78.99 million in cash and 4.58 million in debt, giving a net cash position of 74.41 million or 2.16 per share.

Cash & Cash Equivalents	78.99M
Total Debt	4.58M
Net Cash	74.41M
Net Cash Per Share	2.16
Equity (Book Value)	90.21M
Book Value Per Share	2.63
Working Capital	77.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.81 million and capital expenditures -981,367, giving a free cash flow of -8.80 million.

Operating Cash Flow	-7.81M
Capital Expenditures	-981,367
Free Cash Flow	-8.80M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross margin is 75.38%, with operating and profit margins of -6.44% and -7.45%.

Gross Margin	75.38%
Operating Margin	-6.44%
Pretax Margin	-6.98%
Profit Margin	-7.45%
EBITDA Margin	-4.67%
EBIT Margin	-6.44%
FCF Margin	n/a

Dividends & Yields

SofWave Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.29%
Shareholder Yield	-0.29%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SofWave Medical has an Altman Z-Score of 5.59.

Altman Z-Score	5.59
Piotroski F-Score	n/a